Date:2/28/2011

248,562167,952173,097Provision for income taxes(8,011)(7,513)(28,764)(17,631)Net Income37,41141,049139,188155,466Less: Net income attributable to non-controlling interests----Net Income attributable to the Company37,41141,049139,188155,466Basic earnings per share0.340.361.281.37Diluted earnings per share0.330.351.231.32Shares used in the computation of:Basic earnings per share109,251,426114,627,335108,567,305113,638,024Diluted earnings per share113,673,043117,957,675113,025,775117,581,196(3) Share-based compensation charges incurred during the period related to:Cost of revenues9474467320Selling expenses5487093,4062,569General and administrative expenses7443353,3181,591Research and development expenses6035803,0472,800Exhibit 3MINDRAY MEDICAL INTERNATIONAL LIMITEDRECONCILIATIONS OF NON-GAAP RESULTS OF OPERATIONS MEASURES TO THE NEARESTCOMPARABLE GAAP MEASURES(Dollars in thousands, except for share and per share data)Three months ended
December 31,Year ended
December 31,2009

20102009

2010US$

US$US$

US$(unaudited)

(unaudited)(unaudited)

(unaudited)Non-GAAP net income41,662

45,374147,388

170,944Non-GAAP net margin

22.1%

21.5%23.2%

24.3%Amortization of acquired intangible assets

(2,137)

(1,742)(8,621)

(7,487)Deferred tax impact related to acquired intangible assets

60

34348

208Realignment costs — post acquisition

(185)

(919)(1,446)

(919)Income from early termination contract

-

-11,757

-Share-based compensation

(1,989)

(1,698)(10,238)

(7,280)GAAP net income

37,411

41,049139,188

155,466GAAP net margin

19.8%

19.5%21.9%

22.1%Non-GAAP income per share - basic

0.38

0.401.36

1.50Non-GAAP income per share - diluted

0.37

0.381.30

1.45GAA
'/>"/>

SOURCE Mindray Medical International Limited Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related medicine technology :

1. Mindray Announces FDA 510(k) Clearance of Its A5 Anesthesia System
2. Mindray to Report Fourth Quarter and Full Year 2010 Financial Results on February 28, 2011
3. Mindray Receives its Largest Order of Patients Monitors in Canada
4. Mindray Medical to Exhibit at Arab Health 2011 in Dubai from January 24-27
5. Mindray Medical Announces Preliminary 2010 Operating Results
6. Mindray Medical Meets 2010 Product Development Targets and Announces Strong 2011 Pipeline
7. Mindray Medical Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
8. Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010
9. Mindray Announces Third Quarter 2010 Financial Results
10. Mindray Medical Announces Participation in Upcoming Investor Conferences
11. Mindray to Report Third Quarter 2010 Financial Results on November 8, 2010